Literature DB >> 24133560

Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance.

Rebecca B Saunderson1, Roger Garsia, Alexander P Headley, Geoffrey W McCaughan, Sandra O'Toole, Simone I Strasser.   

Abstract

BACKGROUND: Drug rash with eosinophilia and systemic symptoms (DRESS) is a severe drug reaction characterised by rash, eosinophilia and systemic involvement. MAIN OBSERVATIONS: We report a case of DRESS induced by pentoxifylline used for the treatment of severe alcoholic hepatitis, in a patient with longstanding caffeine intolerance. A history of intolerance to caffeine and other methylxanthines is listed as a contraindication to the use of pentoxifylline, yet this precaution is not mentioned in alcoholic hepatitis treatment guidelines.
CONCLUSIONS: Prescribers should always seek a history of intolerance to caffeine and related compounds prior to use of pentoxifylline, as severe life threatening reactions can occur.

Entities:  

Keywords:  DRESS; adverse drug reaction; alcoholic hepatitis; caffeine; eosinophilia; methylxanthines; pentoxifylline

Year:  2013        PMID: 24133560      PMCID: PMC3797013          DOI: 10.3315/jdcr.2013.1150

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  14 in total

1.  The drug hypersensitivity syndrome: what is the pathogenesis?

Authors:  J R Sullivan; N H Shear
Journal:  Arch Dermatol       Date:  2001-03

2.  EASL clinical practical guidelines: management of alcoholic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2012-05-26       Impact factor: 25.083

3.  Acute generalized exanthematous pustulosis induced by pentoxifylline.

Authors:  Annalisa Patrizi; Michela Tabanelli; Angela Antonucci; Iria Neri
Journal:  Int J Dermatol       Date:  2007-12       Impact factor: 2.736

Review 4.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 5.  Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.

Authors:  H R Dettelbach; D M Aviado
Journal:  J Clin Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.126

6.  Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.

Authors:  Sidharth Mahapatra; Jonathan L Belgrad; Martins A Adeoye
Journal:  Pediatrics       Date:  2010-12-06       Impact factor: 7.124

7.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 9.  Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.

Authors:  S Tas; T Simonart
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 10.  HLA and pharmacogenetics of drug hypersensitivity.

Authors:  Rebecca Pavlos; Simon Mallal; Elizabeth Phillips
Journal:  Pharmacogenomics       Date:  2012-08       Impact factor: 2.533

View more
  1 in total

Review 1.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.